BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 8, 2008
View Archived Issues
LGT/DEN4 tick-borne encephalitis vaccine evaluated in healthy volunteers
Read More
No improvement in cognition seen with CERE-120 in Parkinson's disease patients
Read More
Romiplostim increases platelet counts in immune thrombocytopenic purpura
Read More
XmAb 2513 moves into clinical development
Read More
New therapeutics for thrombotic disorders reported in recent AstraZeneca patents
Read More
New treatment option for Alzheimer's disease disclosed in recent Merck patent
Read More
Renal cancer drug sorafenib inhibits mutant FLT3 in acute myelogenous leukemia
Read More
Recent Solvay patent describes new compounds for substance abuse and dependence
Read More
Meditrina enters into exclusive global license agreement with AstraZeneca
Read More
GSK and Amira enter agreement for FLAP inhibitors for respiratory and cardiovascular disease
Read More
FDA accepts for filing and review UCB's BLA for Cimzia for rheumatoid arthritis
Read More
Forest pays Glenmark a USD 15 million milestone payment for oglemilast for COPD
Read More
BG Medicine and ACS Biomarker enter agreement for biomarker of vascular plaque rupture
Read More
4SC and AiCuris enter collaboration to develop antiinfective drug candidates
Read More
Idera and Merck KGaA receive Hart-Scott-Rodino clearance for collaboration agreement
Read More
Plethora reports preliminary results from PSD-506 incontinence study
Read More
Vermillion and Johns Hopkins agree to co-develop molecular diagnostic tests
Read More
NHLBI changes intensive blood sugar treatment strategy in ACCORD trial
Read More
Study shows efficacy of once-daily atazanavir sulfate/ritonavir in HIV patients
Read More
Apex Bioventures and Dynogen announce definitive merger agreement
Read More
BioNumerik treats first patient in global Karenitecin phase III trial
Read More
Chelsea Therapeutics commences dosing in pivotal phase III droxidopa trial
Read More
Hollis-Eden commences phase I/II Triolex trial in ulcerative colitis
Read More
Insception Biosciences initiates human clinical trials of new stem cell treatment
Read More